ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Strides Pharma Science received a Form 483 with three observations following a routine USFDA inspection at its Alathur formulations facility. The company will respond within stipulated timelines.
Strides Pharma Science received a USFDA Establishment Inspection Report (EIR) for its Bengaluru facility. This confirms the successful closure of the recent cGMP inspection.
Strides Pharma Science Limited has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26, as required under SEBI regulations.
Strides Pharma's Bangalore facility completed a US-FDA inspection with five Form 483 observations. The company plans to respond within the stipulated timeline to ensure compliance.